Clinical Review of Prosthetic Heart Valve Replacement

인공심장판막치환술의 임상적 고찰

  • 장기경 (메리놀병원 흉부외과) ;
  • 윤후식 (메리놀병원 흉부외과, 메리놀병원 흉부외과, 방지거병원 흉부외과, 연세대학교 심장혈과외과, 연세대학교 의과대학 심혈관연구소)
  • Published : 1996.09.01

Abstract

Cardiac valve implantation was performed in 107 patients from September, 1988 to May, 1995. There were 3) men and 74 women, whose ages ranged from 19 to 75 years(mean 42.6$\pm$11.7). Mitral valve was implanted in 61 patients, double(mitral & aortic) valve were Implanted in 28 patients and aortic valve was implanted in 18 patients. Follow up was 100% complete, with 345.6 patient-years and a mean fo low up of 41 months(from 1.5 to 84 months). The total mortality was 14.9%(16 patients). The early mortality was 5.6%(6 patients) and the late mortality was 9.3%(10 patients). The overall actuarial survival was 92.6 $\pm$ 2 6% at 2 years, 88.6$\pm$3.8% at 6 years. The probability of freedom from valve failure, thromboembolism and bacterial endocarditis were 388.6 $\pm$ 3.8, 88.3 $\pm$3.9, 89.5 $\pm$3.7 at 6 years, respectively.

1989년 9월부터 1995년 5월까지 메리놀병원 흉부외과에서는 107례의 환자에서 인공심장판막치환술을 시행하였다. 환자의 연령분포는 19세부터 75세까지 였으며 평균 42.6$\pm$11.7세였고, 남녀비는 33:74였다. 승모판막치환술이 61례(57%)로 가장 많았으며, 중복판막치 환술 28례(26.2%), 대동맥 판막치 환술 18례 (16.8%)였다. 전체 사망율은 14.9%(16명)였으며, 조기사망율은 5.6%(6명), 만기 사망율은 9.3%(10명)이었다. 생존율은 술후 2년에 92.6$\pm$2.6 %, 술후 6년에 88.6$\pm$3.8%였다. 판막실패없는 빈도는 술후 6년에 88.6$\pm$3.8, 혈전전색증없는 빈도는 술후 6년에 88.3$\pm$3.9, 심내막염없는 빈도는 술후 6년에 89.5$\pm$ 3.7를 나타냈다.

Keywords

References

  1. Ann Thorac Surg v.96 Guidelines for reporting morbidity and mortality after cardiac valvular operations Edmunds,L.H.;Clark,R.E.;Cohn,L.H.;Miller,C.;Weisel,R.D.
  2. Ann Thorac Surg v.24 Actuarial analysis of surgical results : rationale and method Grunkemeier,G.L.;Starr,A.
  3. Scand J Thorac Cardiovasc Surg v.5 Clinical and hemodynamic results of aortic valve replacement with the Bjork-Shiley tilting disc valve prosthesis Bjork,V.O.
  4. 대흉외지 v.27 심장판막치환술의 임상적 고찰 강창희;은종화;남충희;이길노
  5. 대흉외지 v.20 심장판막질환의 외과적 치료에 관한 임상적 고찰 박명규
  6. J Thorac Cardiovasc Surg v.47 Mitral valve replacement with preservation of papillary muscles and chordae tendinae Lillehei,C.W.;Levy,M.J.;Bonnabeau,R.C.
  7. Circulation v.68 no.Suppl 2 The importance of the mitral apparatus in left ventricular function after correction of the mitral regurgitation David,T.E.;Uden,D.E.;Strauss,H.D.
  8. Cardiol Clin v.3 Thromboembolic complications of prosthetic valves Addonizio,V.P.;Edmunds,L.H.
  9. 대흉외지 v.25 St. Jude medical 기계판막의 단기 및 중기성적 조범구;장병철;강면식;방정현;홍승록
  10. 대흉외지 v.22 Bjork-Shiley 기계판막의 임상적 연구 김병열;강경훈;이정호;유희성
  11. J Thorac Cardiovasc Surg v.87 The risk of thromboembolism and hemorrhage following mitral valve replacement Gonzalez-Lavin L.;Tandon,A.P.
  12. 대흉외지 v.25 쌍엽기계판막에 관한 임상연구 박계현;백완기;안혁;채헌;김종환
  13. 대흉외지 v.22 후천성 심질환의 인공판막 치환술에 대한 임상적 고찰 이준영;지행옥
  14. J Cardiovasc Surg(Torino) v.32 Bioprosthetic valve endocarditis:factors affecting bad outcome Gagliardi,C.;Di Tommaso L.;Mastroroberto,P.;Stassano,P.;Spampinato,N.